Robert Hickey, president and CEO of SyntheMed, said: “SinusShield represents an example of our strategy to capitalize on our proprietary polymer film technology in new surgical applications both in the US and international markets.
“The company is in discussion with prospective partners with the distribution infrastructure to service the office-based and hospital outpatient sites where these procedures are performed.”